Our previous results confirmed that the differentiation of hepatoma cell lines after syndecan-1 transfection acted together with the changes of an HS pattern to a more sulfated one, as indicated by HS-specific antibodies, capable of interfering with the promoter activation of AP1 and Ets1 [16,75]. The gene discussed is ETS1; the disease is hepatocellular carcinoma.